OCX Oncocyte Corp

OncoCyte Corp focuses on the discovery, development, and commercialization of novel, non-invasive, liquid biopsy diagnostics for the early detection of cancer.

$3.72
As of 03/05/2021     IEX book   CBOE book


Security Information
Category1:
Category2:
Category3:
GICS sector:
Industry:
Index country:
Country of incorporation:
IPO date:
Outstanding shares:
Average volume:
Market cap:
Current dividend yield:
All SEC filings:
Quarterly filings:
Annual filings:
CUSIP:
ISIN:
Sedol:
US Equity
Common stocks
Micro cap
Health Care
Biotechnology
USA
USA
12/30/2015
67,250,639
1,497,734
$250,172,377
0.00%
SEC Edgar Online
10-Q
10-K
68235C107
US68235C1071
BYQRGG0

Valuation   (See tab for details)
PE ratio:
PB ratio:
PS ratio:
Return on equity:
Net income %:
-10.59
7.22
350.38
-91.16%
-4,422.55%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy